1-(1,3-Benzodioxol-5-yl)-N-hydroxypropan-2-amine is a chemical compound featuring a benzodioxole moiety linked to a hydroxyamine group via a propan-2-amine chain. This structure makes it a versatile building block, particularly valued for its hydroxamic acid precursor functionality. Its primary and most significant application is in medicinal chemistry as a key intermediate for the synthesis of histone deacetylase (HDAC) inhibitors. The hydroxamic acid group, which can be derived from this compound, is a critical pharmacophore known for chelating the zinc ion in the active site of HDAC enzymes. This compound serves as a crucial precursor in the development of anticancer agents, such as certain derivatives of vorinostat (SAHA). Furthermore, the presence of both a reactive amine (or hydroxylamine) and a privileged benzodioxole scaffold makes it a candidate for use in constructing linkers for targeted protein degradation (PROTACs) or other bifunctional molecules. It is primarily supplied for research and development purposes in pharmaceutical synthesis.